{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:59:47Z","timestamp":1792601987598,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1124\/mol.117.110742","type":"journal-article","created":{"date-parts":[[2017,11,30]],"date-time":"2017-11-30T18:10:18Z","timestamp":1512065418000},"page":"101-108","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Drugs and Scaffold That Inhibit Cytochrome P450 27A1 In Vitro and In Vivo"],"prefix":"10.1016","volume":"93","author":[{"given":"Morrie","family":"Lam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Mast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina A.","family":"Pikuleva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/mol.117.110742_bib1","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1158\/0008-5472.CAN-16-2738","article-title":"CYP27A1 loss dysregulates cholesterol homeostasis in prostate cancer","volume":"77","author":"Alfaqih","year":"2017","journal-title":"Cancer Res"},{"key":"10.1124\/mol.117.110742_bib2","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ejphar.2011.03.048","article-title":"Selective dihydropyiridine compounds facilitate the clearance of \u03b2-amyloid across the blood-brain barrier","volume":"659","author":"Bachmeier","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/mol.117.110742_bib3","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/MOL.0b013e328362df13","article-title":"Cerebrotendinous xanthomatosis","volume":"24","author":"Bj\u00f6rkhem","year":"2013","journal-title":"Curr Opin Lipidol"},{"key":"10.1124\/mol.117.110742_bib4","doi-asserted-by":"crossref","first-page":"150","DOI":"10.2165\/00002512-199506020-00007","article-title":"Nilvadipine. A review of its pharmacodynamic and pharmacokinetic properties, therapeutic use in hypertension and potential in cerebrovascular disease and angina","volume":"6","author":"Brogden","year":"1995","journal-title":"Drugs Aging"},{"key":"10.1124\/mol.117.110742_bib5","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1194\/jlr.M035790","article-title":"Posttranslational modification by an isolevuglandin diminishes activity of the mitochondrial cytochrome P450 27A1","volume":"54","author":"Charvet","year":"2013","journal-title":"J Lipid Res"},{"key":"10.1124\/mol.117.110742_bib6","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.1016\/S0021-9258(18)34823-3","article-title":"Spectroscopic investigations of ferric cytochrome P-450-CAM ligand complexes. Identification of the ligand trans to cysteinate in the native enzyme","volume":"257","author":"Dawson","year":"1982","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.117.110742_bib7","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1210\/me.2007-0383","article-title":"27-hydroxycholesterol is an endogenous selective estrogen receptor modulator","volume":"22","author":"DuSell","year":"2008","journal-title":"Mol Endocrinol"},{"key":"10.1124\/mol.117.110742_bib8","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1002\/gps.1851","article-title":"Nilvadipine prevents cognitive decline of patients with mild cognitive impairment","volume":"22","author":"Hanyu","year":"2007","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1124\/mol.117.110742_bib9","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1194\/jlr.M500024-JLR200","article-title":"Crossing the barrier: net flux of 27-hydroxycholesterol into the human brain","volume":"46","author":"Heverin","year":"2005","journal-title":"J Lipid Res"},{"key":"10.1124\/mol.117.110742_bib10","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1007\/s00216-008-2244-0","article-title":"Substrate binding to cytochromes P450","volume":"392","author":"Isin","year":"2008","journal-title":"Anal Bioanal Chem"},{"key":"10.1124\/mol.117.110742_bib11","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1084\/jem.20160534","article-title":"27-Hydroxycholesterol impairs neuronal glucose uptake through an IRAP\/GLUT4 system dysregulation","volume":"214","author":"Ismail","year":"2017","journal-title":"J Exp Med"},{"key":"10.1124\/mol.117.110742_bib12","doi-asserted-by":"crossref","first-page":"282","DOI":"10.2174\/1389557513666131119204126","article-title":"1, 4-Dihydropyridines: a class of pharmacologically important molecules","volume":"14","author":"Khedkar","year":"2014","journal-title":"Mini Rev Med Chem"},{"key":"10.1124\/mol.117.110742_bib13","doi-asserted-by":"crossref","unstructured":"Kimbung S, Chang C, Bendahl PO, Dubois L, Thompson WJ, McDonnell DP, Borgquist S (2017) Impact of 27-hydroxylase (CYP27A1) and 27-hydroxycholesterol in breast cancer. Endocr Relat Cancer 24:339\u2013349.","DOI":"10.1530\/ERC-16-0533"},{"key":"10.1124\/mol.117.110742_bib14","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2165\/00003088-199834060-00003","article-title":"Clinical pharmacokinetics of vasodilators. Part I","volume":"34","author":"Kirsten","year":"1998","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/mol.117.110742_bib15","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2165\/00044011-200019040-00004","article-title":"Felodipine in patients with organic solvent-induced chronic toxic encephalopathy","volume":"19","author":"Lindgren","year":"2000","journal-title":"Clin Drug Investig"},{"key":"10.1124\/mol.117.110742_bib16","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1124\/mol.115.099598","article-title":"Marketed drugs can inhibit cytochrome P450 27A1, a potential new target for breast cancer adjuvant therapy","volume":"88","author":"Mast","year":"2015","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.117.110742_bib17","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1124\/mol.112.080424","article-title":"In silico and intuitive predictions of CYP46A1 inhibition by marketed drugs with subsequent enzyme crystallization in complex with fluvoxamine","volume":"82","author":"Mast","year":"2012","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.117.110742_bib18","doi-asserted-by":"crossref","first-page":"4396","DOI":"10.1021\/bi052654w","article-title":"Distinct binding of cholesterol and 5beta-cholestane-3alpha,7alpha,12alpha-triol to cytochrome P450 27A1: evidence from modeling and site-directed mutagenesis studies","volume":"45","author":"Mast","year":"2006","journal-title":"Biochemistry"},{"key":"10.1124\/mol.117.110742_bib19","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1167\/iovs.10-6021","article-title":"Cholestenoic acid is an important elimination product of cholesterol in the retina: comparison of retinal cholesterol metabolism with that in the brain","volume":"52","author":"Mast","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1124\/mol.117.110742_bib20","doi-asserted-by":"crossref","first-page":"14256","DOI":"10.1016\/S0021-9258(18)68214-6","article-title":"Purification and characterization of vitamin D 25-hydroxylase from rat liver mitochondria","volume":"263","author":"Masumoto","year":"1988","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.117.110742_bib21","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1750-3639.2008.00174.x","article-title":"Activity-regulated cytoskeleton-associated protein in rodent brain is down-regulated by high fat diet in vivo and by 27-hydroxycholesterol in vitro","volume":"19","author":"Mateos","year":"2009","journal-title":"Brain Pathol"},{"key":"10.1124\/mol.117.110742_bib22","doi-asserted-by":"crossref","first-page":"669","DOI":"10.3233\/JAD-2011-101512","article-title":"Upregulation of brain renin angiotensin system by 27-hydroxycholesterol in Alzheimer\u2019s disease","volume":"24","author":"Mateos","year":"2011","journal-title":"J Alzheimers Dis"},{"key":"10.1124\/mol.117.110742_bib23","doi-asserted-by":"crossref","first-page":"25574","DOI":"10.1074\/jbc.M111.236877","article-title":"Side chain-oxidized oxysterols regulate the brain renin-angiotensin system through a liver X receptor-dependent mechanism","volume":"286","author":"Mateos","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.117.110742_bib24","doi-asserted-by":"crossref","first-page":"5246","DOI":"10.1158\/0008-5472.CAN-07-6161","article-title":"Mitochondrial cholesterol contributes to chemotherapy resistance in hepatocellular carcinoma","volume":"68","author":"Montero","year":"2008","journal-title":"Cancer Res"},{"key":"10.1124\/mol.117.110742_bib25","first-page":"212","article-title":"Steroid hormone synthetic pathways in prostate cancer","volume":"2","author":"Mostaghel","year":"2013","journal-title":"Transl Androl Urol"},{"key":"10.1124\/mol.117.110742_bib26","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1126\/science.1241908","article-title":"27-Hydroxycholesterol links hypercholesterolemia and breast cancer pathophysiology","volume":"342","author":"Nelson","year":"2013","journal-title":"Science"},{"key":"10.1124\/mol.117.110742_bib27","doi-asserted-by":"crossref","first-page":"382","DOI":"10.2174\/156802611794480882","article-title":"Assessment of cytochrome p450 enzyme inhibition and inactivation in drug discovery and development","volume":"11","author":"Nettleton","year":"2011","journal-title":"Curr Top Med Chem"},{"key":"10.1124\/mol.117.110742_bib28","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.clpt.2005.09.004","article-title":"In vitro cytochrome P450 inhibition data and the prediction of drug-drug interactions: qualitative relationships, quantitative predictions, and the rank-order approach","volume":"78","author":"Obach","year":"2005","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/mol.117.110742_bib29","doi-asserted-by":"crossref","first-page":"18138","DOI":"10.1016\/S0021-9258(19)81335-2","article-title":"Purification and characterization of 5 beta-cholestane-3 alpha,7 alpha,12 alpha-triol 27-hydroxylase from female rat liver mitochondria","volume":"263","author":"Okuda","year":"1988","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.117.110742_bib30","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2119\/molmed.2010.00180","article-title":"Selective antihypertensive dihydropyridines lower A\u03b2 accumulation by targeting both the production and the clearance of A\u03b2 across the blood-brain barrier","volume":"17","author":"Paris","year":"2011","journal-title":"Mol Med"},{"key":"10.1124\/mol.117.110742_bib31","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.brainres.2003.11.061","article-title":"Nilvadipine antagonizes both Abeta vasoactivity in isolated arteries, and the reduced cerebral blood flow in APPsw transgenic mice","volume":"999","author":"Paris","year":"2004","journal-title":"Brain Res"},{"key":"10.1124\/mol.117.110742_bib32","doi-asserted-by":"crossref","first-page":"5314","DOI":"10.1021\/bi00366a049","article-title":"Crystal structure of substrate-free Pseudomonas putida cytochrome P-450","volume":"25","author":"Poulos","year":"1986","journal-title":"Biochemistry"},{"key":"10.1124\/mol.117.110742_bib33","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/0014-5793(92)80847-A","article-title":"Direct expression in Escherichia coli and characterization of bovine adrenodoxins with modified amino-terminal regions","volume":"300","author":"Sagara","year":"1992","journal-title":"FEBS Lett"},{"key":"10.1124\/mol.117.110742_bib34","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1248\/bpb.16.627","article-title":"Direct expression of adrenodoxin reductase in Escherichia coli and the functional characterization","volume":"16","author":"Sagara","year":"1993","journal-title":"Biol Pharm Bull"},{"key":"10.1124\/mol.117.110742_bib35","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0026-895X(25)14748-2","article-title":"Spectral studies of drug interaction with hepatic microsomal cytochrome","volume":"3","author":"Schenkman","year":"1967","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.117.110742_bib36","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0304-3940(92)90894-D","article-title":"Nilvadipine as a neuroprotective calcium entry blocker in a rat model of global cerebral ischemia. A comparative study with nicardipine hydrochloride","volume":"141","author":"Takakura","year":"1992","journal-title":"Neurosci Lett"},{"key":"10.1124\/mol.117.110742_bib37","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1038\/nm1641","article-title":"27-Hydroxycholesterol is an endogenous SERM that inhibits the cardiovascular effects of estrogen","volume":"13","author":"Umetani","year":"2007","journal-title":"Nat Med"},{"key":"10.1124\/mol.117.110742_bib38","doi-asserted-by":"crossref","first-page":"3800","DOI":"10.1016\/S0021-9258(17)43166-8","article-title":"Hydroxylations in biosynthesis of bile acids. Isolation of a cytochrome P-450 from rabbit liver mitochondria catalyzing 26-hydroxylation of C27-steroids","volume":"259","author":"Wikvall","year":"1984","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.117.110742_bib39","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.celrep.2013.10.006","article-title":"27-Hydroxycholesterol promotes cell-autonomous, ER-positive breast cancer growth","volume":"5","author":"Wu","year":"2013","journal-title":"Cell Reports"},{"key":"10.1124\/mol.117.110742_bib40","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1194\/jlr.M053439","article-title":"Pathways of cholesterol homeostasis in mouse retina responsive to dietary and pharmacologic treatments","volume":"56","author":"Zheng","year":"2015","journal-title":"J Lipid Res"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24007211?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24007211?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.117.110742","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T10:23:11Z","timestamp":1739960591000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24007211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S0026895X24007211"],"URL":"https:\/\/doi.org\/10.1124\/mol.117.110742","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drugs and Scaffold That Inhibit Cytochrome P450 27A1 In Vitro and In Vivo","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.117.110742","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}